Lindbrook Capital’s Evolus EOLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$132 Buy
+11
New +$144 ﹤0.01% 2742
2024
Q4
Sell
-21
Closed -$340 2817
2024
Q3
$340 Buy
+21
New +$294 ﹤0.01% 2741
2023
Q3
Sell
-4
Closed -$29 2723
2023
Q2
$29 Buy
+4
New +$35 ﹤0.01% 2685
2022
Q4
Sell
-73
Closed -$1K 2882
2022
Q3
$1K Sell
73
-127
-64% -$1.35K ﹤0.01% 2306
2022
Q2
$2K Hold
200
﹤0.01% 1945
2022
Q1
$2K Buy
+200
New +$1.71K ﹤0.01% 1978
2021
Q3
Sell
-293
Closed -$4K 1889
2021
Q2
$4K Buy
+293
New +$3.22K ﹤0.01% 1355

Other funds holding EOLS

Lindbrook Capital's EOLS Position: Q1 2025 in Review

Lindbrook Capital opened a new position in Evolus (EOLS) in Q1 2025: 11 shares worth $132. The stake represents ﹤0.01% of the portfolio and ranks #2742 among its holdings. This is a return to the name: Lindbrook Capital previously reported a position in EOLS as recently as Q3 2024.

Lindbrook Capital first reported a position in EOLS in Q2 2021 and has held it in 7 quarters since. The position peaked at $4K in Q2 2021. 179 funds tracked by Wall St. Rank hold EOLS as of Q1 2025.

  • Lindbrook Capital held 11 shares of Evolus worth $132 as of Q1 2025.
  • Evolus was a new Lindbrook Capital position in Q1 2025.
  • Evolus made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2742 holding.
  • Lindbrook Capital first reported a position in Evolus in Q2 2021 and has held it in 7 quarters since.
  • Lindbrook Capital's Evolus position peaked at $4K in Q2 2021.
  • 179 funds tracked by Wall St. Rank held Evolus as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.